Robinhood shares gain on Q2 beat, as user and crypto growth accelerate
INDIANAPOLIS - Corteva, Inc. (NYSE:CTVA), the $49.4 billion market cap agriculture company, announced Tuesday its Board of Directors has authorized a quarterly common stock dividend of $0.18 per share, representing a nearly 6% increase from its previous dividend. This continues the company’s strong dividend growth track record, having raised dividends for 6 consecutive years, with a current yield of 0.94%.
The dividend will be payable on September 15, 2025, to shareholders of record as of September 2, 2025. This marks Corteva’s fifth dividend increase since its spin-off in 2019, according to the company’s press release statement. The company’s strong dividend policy is supported by its solid financial health, which InvestingPro analysis rates as "GOOD" based on comprehensive metrics including profitability and cash flow scores.
Additionally, the Board of Directors of EIDP, Inc., a wholly owned subsidiary of Corteva formerly known as E. I. du Pont de Nemours and Company, declared regular preferred stock dividends. These include $1.12-1/2 per share on the $4.50 series preferred stock and $0.87-1/2 per share on the $3.50 series preferred stock, both payable October 24, 2025, to EIDP stockholders of record on October 3, 2025.
Corteva, which operates as a global agriculture company, offers seed, crop protection, and digital products and services. The company was formed following a spin-off in 2019 and has since implemented regular dividend increases as part of its capital return strategy to shareholders.
In other recent news, Corteva Inc. has seen several developments that could impact investor decisions. RBC Capital and BMO Capital both raised their price targets for Corteva, setting them at $85 and $86, respectively, while maintaining an Outperform rating. RBC Capital slightly increased its EBITDA estimates for Corteva, citing confidence in the company’s future guidance and targets. Similarly, BMO Capital adjusted its 2025 EBITDA estimates to the upper end of Corteva’s guidance range and projected 2026 EBITDA above consensus. Jefferies also reiterated a Buy rating on Corteva, raising its price target to $92 and highlighting the company’s growth potential and unique position in addressing climate change impacts. Furthermore, Corteva has entered into a multi-year research collaboration with Micropep Technologies to develop peptide-based crop protection solutions. This partnership will leverage Corteva’s agricultural expertise and Micropep’s technology to create new biofungicides and disease control products, with Corteva receiving exclusive global rights for specific applications.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.